IKS014 in Advanced Solid Tumors That Express HER2

Clinical trial NCT05872295 · RECRUITING

Trial details

NCT number: NCT05872295
Sponsor: Iksuda Therapeutics Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Gastric Cancer Gastroesophageal-junction Cancer

Start date: 2023-09-14
Primary completion: 2026-12-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.